Combined metabolic-reproductive association and predictive value of AMH and TyG index in PCOS: a single-center retrospective study - Scorecard - MDSpire
Advertisement
Combined metabolic-reproductive association and predictive value of AMH and TyG index in PCOS: a single-center retrospective study
Clinical Scorecard: Investigating the Combined Metabolic and Reproductive Relationships of AMH and TyG Index in PCOS: A Retrospective Analysis from a Single Center
At a Glance
Category
Detail
Condition
Polycystic Ovary Syndrome (PCOS)
Key Mechanisms
Anti-Müllerian hormone (AMH) and triglyceride-glucose (TyG) index as independent and synergistic risk factors.
Target Population
Women of reproductive age with PCOS.
Care Setting
Reproductive Endocrinology & Infertility and General Gynecology clinics.
Key Highlights
AMH and TyG index are independent risk factors for PCOS.
Significant interaction between AMH and TyG index in predicting PCOS risk.
Higher risk of PCOS correlates with increasing levels of AMH and TyG index.
The predictive model combining AMH and TyG index shows the highest accuracy (AUC = 0.693).
PCOS affects approximately 6% to 22% of women of reproductive age.
Guideline-Based Recommendations
Diagnosis
Utilize Rotterdam diagnostic criteria for PCOS identification.
Management
Consider AMH and TyG index in risk assessment and stratification.
Monitoring & Follow-up
Monitor metabolic parameters alongside reproductive health indicators.
Risks
Long-term complications include type 2 diabetes, cardiovascular disease, and infertility.
Patient & Prescribing Data
Women diagnosed with PCOS.
Focus on managing both reproductive and metabolic aspects.
Clinical Best Practices
Integrate reproductive and metabolic assessments for individualized patient management.
Utilize biomarkers like AMH and TyG index for enhanced risk stratification.
Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.
